Delivery Order SPE2DB20D3103-SPE2DB23FP3P9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,612.34 for Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of January 8, 2024 and uses a firm fixed price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,366.34 Firm Fixed Price Delivery Order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $3,697.45 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 19, 2023, with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,805.26 delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has an ultimate completion date of April 12, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $8,824.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 22, 2023. This contract is a delivery order and has a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. The Firm Fixed Price contract, valued at $14,519.97, has an ultimate completion date of August 29, 2023. This is a Delivery Order awarded under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,297.54 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen with a 3 mL capacity. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $51,308.77 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 6, 2024. The contract is not designated as a set-aside award. Amerisourcebergen is the prime contractor for this delivery order, which is part of a larger $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $6,639.24 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is not set aside for any specific business type. The contract has an ultimate completion date of July 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,959.79 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP3P9Delivery Order
This federal contract award for $3,340.54 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. The award has an ultimate completion date of August 15, 2023 and is structured as a firm fixed-price contract. Amerisourcebergen is a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/14/23 |